We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA WARNS PHARMPAK FOR POSSIBLE CROSS-CONTAMINATION
FDA WARNS PHARMPAK FOR POSSIBLE CROSS-CONTAMINATION
May 3, 2004
The FDA has issued a warning letter to California-based drug repackaging firm PharmPak, after discovering that deficiencies in the firm’s repackaging process may have resulted in cross-contamination between penicillin and nonpenicillin products.